Early Diagnosis of Kidney Damage Associated With Tobacco Use

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

April 1, 2022

Study Completion Date

July 1, 2022

Conditions
Kidney InjuryKidney Disease, ChronicTobacco Toxicity
Interventions
DIAGNOSTIC_TEST

Early kidney damage biomarkers

In the urine samples of these patients, a series of biomarkers of early kidney damage and / or predisposition to kidney damage will be measured.

DIAGNOSTIC_TEST

Predisposition to kidney injury biomarkers

In the urine samples of these patients, a series of biomarkers of predisposition to kidney damage will be measured.

DIAGNOSTIC_TEST

Tobacco consumption

In order to know the degree of tobacco consumption, the biomarker cotinine will be measured in the urine samples of these patients.

Trial Locations (2)

Unknown

Centro de Salud La Alamedilla, Salamanca

Unidad de tabaquismo del CAUSA, Salamanca

All Listed Sponsors
collaborator

Instituto de Investigación Biomédica de Salamanca

OTHER

collaborator

Grupo de Investigación de Atención Primaria de Castilla y León

OTHER_GOV

collaborator

Salamanca University Hospital

OTHER

collaborator

Instituto de Salud Carlos III

OTHER_GOV

lead

Fundación Instituto de Estudios de Ciencias de la Salud de Castilla y León

OTHER

NCT03850756 - Early Diagnosis of Kidney Damage Associated With Tobacco Use | Biotech Hunter | Biotech Hunter